Autoantibodies, C-reactive protein, erythrocyte sedimentation rate and serum cytokine profiling in monitoring of early treatment

INTRODUCTION: Currently used clinical scale and laboratory markers to monitor patients with early rheumatoid arthritis (RA) seem to be not sufficient. It has been demonstrated that disease- related cytokines may be elevated very early in RA development and cytokines are considered as the biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales: Brzustewicz, Edyta, Henc, Izabella, Daca, Agnieszka, Szarecka, Maria, Sochocka-Bykowska, Malgorzata, Witkowski, Jacek, Bryl, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Society of Experimental and Clinical Immunology 2017
Materias:
Clinical Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708207/
https://www.ncbi.nlm.nih.gov/pubmed/29204090
http://dx.doi.org/10.5114/ceji.2017.70968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708207/
https://www.ncbi.nlm.nih.gov/pubmed/29204090
http://dx.doi.org/10.5114/ceji.2017.70968

Ejemplares similares